NCT00005976 2013-06-03
Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
7 trialsNCT00002656 2013-04-29
Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00053950 2013-04-09
Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00003041 2013-01-31
Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003802 2012-12-17
Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00002585 2012-03-12
Pyrazoloacridine in Treating Women With Metastatic Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00003714 2012-02-22
Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn